Aristotle University Of Thessaloniki (AUTH)
Κατάγματα ισχίου σε γυναίκες μετεμμηνοπαυσιακής ηλικίας σε σχέση με το μεταβολισμό και τη ποσότητα του λιπώδους ιστού
Abstract
dc:descriptionAim. The main question of this study is the possible correlation of the markers of adipose tissue metabolism with the risk of hip fracture in postmenopausal women. The answer is sought through clinical evaluation and biochemical and hormonal parameters that regulate bone reconstruction and fat tissue metabolism. The following parameters were studied: • The frequency of obesity in postmenopausal women with hip fracture. • The measurement of adiponectin (ADP), osteoprotegerin (OPG), sclerostin (SCL), 25-hydroxy-vitamin D (25OHD3), calcium (Ca) and parathyroid hormone (PTH). • The association between the lipokins and the factors regulating bone mass and the increased fracture risk in postmenopausal women. • Finally, the investigation of the strength of this correlation according to the age and body mass index of the women.Material and methods. 110 postmenopausal women with osteoporosis were studied. Of these, 80 were patients (cases) who had suffered a hip fracture and 30 were controls. During the admission of the women to the Orthopaedic Clinic (patients) or their follow-up in the outpatients Osteoporosis Clinic (cases), detailed personal, family and social history was obtained. At the same time, full clinical examination was performed and anthropometric parameters were recorded: height, weight (to calculate the body mass index) and waist circumference. Blood samples were also collected. Tests carried out at the hospital laboratory included serum glucose, urea, creatinine, sodium and potassium. A separate blood sample was taken for the additional tests: The blood was centrifuged and kept at -80°C until the measurements of adiponectin (ADP), osteoprotegerin (OPG), sclerostin (SCL), 25 hydroxy-vitamin D (25OHD3), calcium (Ca) and parathyroid hormone (PTH). These analyses were carried out by a certified reference center in accordance with the methods accepted by the international literature. Biostatistical analysis was carried out with the student t-test. The statistical significance of the findings was checked by the calculation of p-value and also the correlation of the findings with the calculation of coefficient r with the use of Spearman test. Finally, the various parameters were examined for the possible existence of regression and the degree of its strength; both between the parameters themselves and with the anthropometric parameters of the study. Results. Data analysis showed that the body mass index of women who suffered a hip fracture was 29,3±3,6 kg/m2. Levels of vitamin D and calcium in postmenopausal women with osteoporosis who suffered a fracture (patients) were significantly lower than in postmenopausal women with osteoporosis without a fracture (controls). This difference between patients and controls remained statistically significant for all body mass index (BMI) and age subgroups. In terms of adiponectin, two were the key findings. First, there was a negative correlation of adiponectin levels with BMI in patients (r=-0,286; p=0.027) of all subgroups. In fact, adiponectin concentrations showed an even more pronounced negative correlation with waist circumference than with BMI (r=-0,353; p=0,006). The second key finding was the significant difference (p<0.001) in adiponectin concentrations between postmenopausal women with fracture (patients, 11.7±4.9 µg/ml) and postmenopausal women with no fracture (controls, 15.2±4.5 µg/ml). With regards to osteoprotegerin, this study showed concentrations that showed no significant differences between patients and controls. There were also no differences between patients according to their BMI or age, nor statistically significant correlations with other parameters of the study. Finally, this study showed a difference in sclerostin concentrations between women with and without fracture that was marginally not statistically significant (p=0.057). Conclusions: The main conclusions of this study were: 1. Lower concentrations of adiponectin, calcium, parathyroid hormone and vitamin D were found in the serum of postmenopausal women with osteoporosis and fracture (patients), than in postmenopausal women with osteoporosis without fracture (controls). 2. There were no differences in the concentrations of osteoprotegerin in patients and controls. 3. Sclerostin concentrations were higher in the control group than in patients, a finding that applies to all age and body mass index subgroups. This difference was marginally non-statistically significant overall. 4. Adiponectin concentrations showed a moderately strong negative correlation with both body mass index and - mainly- waist circumference. 5. In the subgroup of obese women, statistically significantly higher concentrations of adiponectin were observed in women with osteoporosis without fracture compared to those with osteoporosis and fracture. 6. This study showed high rates of obesity in postmenopausal women with osteoporosis and hip fracture. This finding is likely a reflection of the increased incidence of obesity in the general population in Greece. It would be particularly useful to establish and maintain a hip fracture registry at national level which would allow safe epidemiological data to be extracted. 7. The difference in vitamin D and calcium concentrations (higher in women with osteoporosis without fracture) may be explained by the regular follow-up of these women in the osteoporosis outpatient clinic which led to early initiation of vitamin D replacement therapy and optimal patient compliance with the treatment. At the same time, however, low concentrations of vitamin D and calcium in women with diagnosed osteoporosis and hip fracture indicate poor treatment of vitamin D deficiency in the community. 8. From all the above, it becomes apparent that the relationship between the bone and the adipose tissue is complex and dynamic. It appears that adiponectin concentrations in obese women may serve as a predictor for fracture occurrence, while further research is needed in larger populations of women on the possible corresponding use of sclerostin levels.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gkastaris, Konstantinos
- Γκάσταρης, Κωνσταντίνος
Subjects
dc:subject × 18- Οστεοπόρωση
- Κάταγμα ισχίου
- Λιπώδης ιστός
- Αντιπονεκτίνη
- Σκληροστίνη
- Οστεοπροτεγερίνη (OPG)
- Μετεμμηνοπαυσιακή οστεοπόρωση
- Osteoporosis
- Hip fractures
- Adipose tissue
- Adiponectin
- Sclerostin
- Osteoprotegerin (OPG)
- Postmenopausal osteoporosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47788